Davao City Rep. Nograles: House willing to draft Dengvaxia aid budget

0 437

Davao City 1st District Rep. Karlo Nograles, chair of the House committee on appropriations, offered Friday to draft a supplemental budget for the Dengvaxia victims if the Department of Health (DOH) failed to come up again with an acceptable proposal.

In a television interview, Nograles said he expects from Health Secretary Francisco Duque III a revised proposed supplemental budget when they meet again on Tuesday, May 22.

“That’s why Tuesday, whether they present to me a good budget or not, if it’s not a good budget, kami na maghihimay. I will approve it on Tuesday, send it to floor, have it approved on the last week [of the second regular session] kasi we’re going to go on break, and send it to the Senate,” Nograles said in an interview on ANC Headstart.

During the hearing last Wednesday, May 16, for the P1.16-billion proposed supplemental budget to be used for the recipients of Dengvaxia vaccine, Nograles told Duque to revise its proposal, removing the allocation for medical kits, which he believed was useless already given the circumstances.

Nograles wanted the DOH to focus instead on identifying the children who received Dengvaxia vaccine so that the necessary assistance could be provided to them.

Some parents have blamed the government for the death of their children after they received the supposedly anti-dengue vaccine.

“What I want from the DOH is to show me a real deployment plan that will address the issues of the parents. What they want really is a no-nonsense monitoring of their children,” Nograles said.

“It’s very different policy-wise when you’re making policies. That what I said…it’s different when you’re up and making policy, it’s different on the ground. So we really have to listen on the ground if it’s really actually happening. The parents say it’s not happening,” he stressed.

Nograles earlier filed House Bill No. 7449 or the proposed Supplemental Budget for 2018, which seeks to utilIze the P1.16-billion refund given to the Philippine government by Dengvaxia manufacturer Sanofi Pasteur of France.